CINECA IRIS Institutional Research Information System

MARIANO, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.009
EU - Europa 2.222
AS - Asia 1.389
OC - Oceania 24
AF - Africa 20
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.966
CN - Cina 753
IT - Italia 590
IE - Irlanda 357
SE - Svezia 274
FR - Francia 222
SG - Singapore 219
UA - Ucraina 199
DE - Germania 185
KR - Corea 102
FI - Finlandia 85
PL - Polonia 76
VN - Vietnam 74
GB - Regno Unito 70
JP - Giappone 66
BE - Belgio 52
CA - Canada 37
TW - Taiwan 36
AT - Austria 34
ID - Indonesia 24
IN - India 23
AU - Australia 22
TH - Thailandia 20
UZ - Uzbekistan 20
HK - Hong Kong 16
ES - Italia 14
CH - Svizzera 10
GR - Grecia 10
NL - Olanda 10
PH - Filippine 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
RU - Federazione Russa 6
SN - Senegal 6
NG - Nigeria 5
RO - Romania 5
TR - Turchia 5
BR - Brasile 4
MY - Malesia 4
AR - Argentina 3
EU - Europa 3
IR - Iran 3
KH - Cambogia 3
LT - Lituania 3
MX - Messico 3
PE - Perù 3
ZA - Sudafrica 3
BG - Bulgaria 2
CL - Cile 2
CU - Cuba 2
EC - Ecuador 2
IL - Israele 2
KW - Kuwait 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TG - Togo 2
TN - Tunisia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
LU - Lussemburgo 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.685
Salva come PNG Salva come JPEG
Città #
Beijing 481
Chandler 449
Dublin 357
Torino 167
Singapore 166
Ann Arbor 164
Houston 164
Villeurbanne 161
Fairfield 137
Jacksonville 118
Princeton 118
Wilmington 90
Medford 89
Ashburn 86
Nyköping 80
Boston 72
Warsaw 68
Dearborn 63
Woodbridge 62
Cambridge 61
Milan 49
Pisa 47
Turin 44
Seattle 42
Dong Ket 39
Redwood City 35
Vienna 31
Shanghai 30
Nanjing 29
Brussels 28
Taipei 26
Jakarta 23
Boardman 22
Fremont 22
Norwalk 20
Guangzhou 19
New York 18
Santa Clara 17
Tokyo 17
Toronto 17
Verona 16
Rome 15
Wuhan 15
Hefei 14
Washington 14
Jinan 13
Xian 13
Gent 12
San Diego 12
Duncan 11
Hangzhou 11
Seoul 11
Philadelphia 10
Changsha 9
Hebei 9
Shenyang 9
Asahikawa 8
Bangkok 8
Buffalo 8
Falls Church 8
Florence 8
Frankfurt am Main 8
Munich 8
Pittsburgh 8
Kunming 7
Malo 7
Paris 7
Pune 7
San Mateo 7
Athens 6
Hanoi 6
Los Angeles 6
Catania 5
Central 5
Charlottesville 5
Düsseldorf 5
Hong Kong 5
Magenta 5
Mayen 5
Mountain View 5
Zhengzhou 5
Abuja 4
Atlanta 4
Aurora 4
Bethesda 4
Busto Arsizio 4
Chengdu 4
Detroit 4
Guiyang 4
Lachine 4
Madrid 4
Nanchang 4
Ottawa 4
Rochester 4
Antwerpen 3
Basel 3
Büdingen 3
Cagliari 3
Cincinnati 3
Fuzhou 3
Totale 4.154
Salva come PNG Salva come JPEG
Nome #
Determination by LC-MS/MS of colistin A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous haemodiafiltration 315
Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies 302
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 274
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 205
Nomenclature for renal replacement therapy in acute kidney injury: Basic principles 202
Coupled-plasma filtration and adsorption for severe burn patients with septic shock and acute kidney injury treated with renal replacement therapy 155
Citrate pharmacokinetics at high levels of circuit citratemia during coupled plasma filtration adsorption 134
Effect of cytokines on the cytoskeleton of resident glomerular cells. 123
[Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries] 123
Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits 120
Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: Practical applications 118
Elevated thrombopoietin in plasma of burned patientswithout and with sepsis enhances platelet activation 112
Circulating plasma factors induce tubular and glomerular alterations in septic burns patients 106
Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction 100
Urinary protein profiles in ketorolac-associated acute kidney injury in patients undergoing orthopedic day surgery 97
Thrombopoietin modulates cardiac contractility in vitro and contributes to myocardial depressing activity of septic shock serum 97
Metformin, chronic nephropathy and lactic acidosis: a multi-faceted issue for the nephrologist 96
Production of platelet-activating factor in patients with sepsis-associated acute renal failure. 92
Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production 92
Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury 91
The MEST score provides earlier risk prediction in lgA nephropathy 89
Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. 86
[CAPD versus hemodialysis. 7 years' experience at the Centro Dialisi in Alba] 84
Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes 83
Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients 81
Renal vascular effects of cytokines. 80
Alterazioni immunologiche in corso di uremia cronica. 78
Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist. 76
[Renal biopsy practice in Piedmont and Valle d'Aosta] INDAGINE SULLE MODALITÀ DI ESECUZIONE DELLA BIOPSIA RENALE IN PIEMONTE E VALLE D’AOSTA 76
Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies 74
Focusing on the basic principles of dialysis to optimize regional citrate anticoagulation 73
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change 71
Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. 71
Regional citrate anticoagulation in critically Ill patients treated with plasma filtration and adsorption 71
IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). 70
An unusual case of extensive self-inflicted cement burn. 70
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. 70
[Anticoagulation of extracorporeal circuit in critically ill patients] 70
Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients 70
The role of platelet-activating factor in experimental immune complex pathology 68
Unravelling the enigma of proteinuria in burn patients 68
Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug 67
Effect of platelet-activating factor (PAF) on human cardiac muscle. 66
Immunomodulation and biomaterials. 63
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 60
[Dialytic therapy in severely burnt patients with acute renal failure] 58
[Acute pielonephritis and renal abscesses in Piedmont and Aosta Valley] 56
Increase of continuous treatments and regional citrate anticoagulation during renal replacement therapy in the ICUs of the north-west of Italy from 2007 to 2015 56
The complement system in sepsis: from new insights into its pathogenesis to future therapeutic approaches 55
Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. 53
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 53
Alterations of the cytokine network in hemodialysis 52
Dosaggio di colistina A e B in pazienti critici trattati con emodiafiltrazione veno-venosa continua (CVVHDF) 50
Metformin-Associated Lactic Acidosis Undergoing Renal Replacement Therapy in Intensive Care Units: A Five-Million Population-Based Study in the North-West of Italy 50
Study protocol: the DOse REsponse Multicentre International collaborative initiative (DO-RE-MI) 50
Long-term preservation of renal function in septic shock burn patients requiring renal replacement therapy for acute kidney injury 50
Is there a real alternative anticoagulant to heparin in continuous treatments? 49
Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. 48
[Substitutive therapies in sepsis and acute renale failure] 47
CAPD versus hemodialysis (HD): 7 years of experience 47
Protective effect of Verapamil on the cardiac and circulatory alterations induced by Platelet activating factor 45
[Citrate: a different mental approach to extracorporeal circuit anticoagulation] 45
Can we obtain a further reduction of peritonitis episodes in CAPD patients already using a Y-set with disinfectant? 44
The role of platelet-activating factor in the biocompatibility of hemodialysis membranes 44
Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments. 44
Critical Care Nephrology: Humoral mediators in sepsis. 43
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. 43
Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart 42
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 42
Role of platelet-activating factor in hypotension andplatelet activation induced by infusion of thrombolytic agents in rabbits. 40
La sepsi e lo shock settico. 39
Platelet activating factor is produced during infectious peritonitis in CAPD patients 38
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy 38
Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients 36
[Nephrologist and ICU: the need of new expertise] 35
Humoral mediators in sepsis 35
Burns and Acute Kidney Failure 35
Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. 34
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 33
[Complications of peritoneal dialysis related to the insertion and/or presence of permanent peritoneal catheters] 32
[Evaluation of nutritional status in a group of patients undergoing CAPD] 32
Role of alpha 1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients 31
Leukocyte-derived mediators and biocompatibility 31
[Insufficient correction of blood bicarbonate levels in biguanide lactic acidosis treated with CVVH and bicarbonate replacement fluids] 30
Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. 30
Renal replacement therapy in intensive care units: a survey of nephrological practice in northwest Italy 29
[Systemic mucormycosis in dialysis: computed tomography picture and histologic lesions] 29
Urine volume as a predicting factor for furosemide clearance during continuous infusion in AKI septic shock patients on hemodiafiltration 29
P.049 Investigation of Novel Circulating Biomarkers in Burn Septic Shock Patients 28
Colistin Therapy, Survival and Renal Replacement Therapy in Burn Patients: A 10-Year Single-Center Cohort Study 28
Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology 28
CAN TONSILLECTOMY MODIFY THE INNATE AND ADAPTIVE IMMUNITY PATHWAYS INVOLVED IN IGA NEPHROPATHY? 28
Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis 27
Safety and Metabolic Tolerance of Citrate Anticoagulation in Critically Ill Polytrauma Patients with Acute Kidney Injury Requiring an Early Continuous Kidney Replacement Therapy 26
The DOse REsponse Multicentre International Collaborative Initiative (DO-RE-MI) 26
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy 25
CytoSorb® in burn patients with septic shock and Acute Kidney Injury on Continuous Kidney Replacement Therapy is associated with improved clinical outcome and survival 24
[Nephroangiosclerosis as a cause of uremia] 24
Efficacy of continuous venovenous haemofiltration (CVVH) in the treatment of severe phenformin-induced lactic acidosis 23
Role of PAF and coagulation in sepsis 23
Totale 6.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.797
article - articoli 0
book - libri 0
conference - conferenze 301
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.098
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020808 0 0 0 61 57 126 125 76 85 88 146 44
2020/2021935 59 48 77 42 103 63 85 58 120 77 85 118
2021/20221.013 32 53 36 60 30 86 71 45 46 97 207 250
2022/20231.416 162 101 41 103 155 367 121 67 171 20 61 47
2023/2024655 101 117 39 44 30 56 11 20 21 42 55 119
2024/2025220 22 115 49 34 0 0 0 0 0 0 0 0
Totale 7.175